Firefly Neuroscience, Inc.
Other Technology · Kenmore, New York
Firefly Neuroscience, Inc. is a other technology company based in Kenmore, New York, incorporated in 2021. It has raised at least $18.8 million across 7 known rounds, of which $16.6 million was reported to the SEC on 7 Form D filings, most recently in 2025.
Firefly Neuro delivers FDA-cleared brain health technology, using EEG and ERP to help clinicians detect, diagnose, and monitor neurological conditions with greater clarity.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2026-04-16 | — | $2.3M | $18.8M | SEC Form D | |
| 2025-06-23 | — | $1.2M | $16.6M | SEC Form D | |
| 2022-08-22 | — | $1.9M | $15.4M | SEC Form D | |
| 2022-07-19 | — | $0 | $13.5M | SEC Form D | |
| 2021-12-20 | — | $10.0M | $13.5M | SEC Form D | |
| 2021-08-30 | — | $2.8M | $3.5M | SEC Form D | |
| 2021-04-22 | — | $200K | $696K | SEC Form D | |
| 2021-04-13 | — | $496K | $496K | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.